Testicular cancer is the leading cause of cancer for men in their 20s and 30s. When detected early, it is a highly treatable type of cancer.
Testicular cancer is highly curable, with survival rates well over 90%, especially if detected and treated early. Although it is rare, it is still the leading cause of cancer in young men in their 20s and 30s.
City of Hope is constantly developing new therapies to eradicate testicular cancer and help you return to an active, healthy life. We conduct a wide variety of clinical trials, many of them not available to the general public.
Located in Southern California, City of Hope is a nationally recognized leader in researching and treating urologic cancers and has been named by U.S. News & World Report as one of America's top urology and cancer hospitals.
Our Testicular Cancer Program Highlights:
State-of-the-art diagnostic tools
Minimally invasive robotic-assisted surgery using the da Vinci surgical system
Radiation therapy, including helical TomoTherapy and brachytherapy
Pioneering drug research and clinical trials
Novel chemotherapy regimens
Long-term family and survivorship supportive care programs
City of Hope's renowned physicians and researchers utilize the latest technology and innovation to treat testicular cancer, coupled with our enduring belief in providing unparalleled compassionate care.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.